Heartflow Inc
HTFL27.740USD
+1.750+6.73%
終値 02/06, 16:00（ET）15分遅れの株価
2.32B時価総額
損失額直近12ヶ月PER
詳細情報 Heartflow Inc 企業名
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Heartflow Incの企業情報
企業コードHTFL
会社名Heartflow Inc
上場日Aug 08, 2025
最高経営責任者「CEO」Farquhar (John C. M)
従業員数699
証券種類Ordinary Share
決算期末Aug 08
本社所在地331 E Evelyn Avenue
都市MOUNTAIN VIEW
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94041
電話番号16502411221
ウェブサイトhttps://www.heartflow.com/
企業コードHTFL
上場日Aug 08, 2025
最高経営責任者「CEO」Farquhar (John C. M)
Heartflow Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Tue, Feb 3
更新時刻: Tue, Feb 3
株主統計
種類
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
他の
61.76%
株主統計
株主統計
比率
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
他の
61.76%
種類
株主統計
比率
Investment Advisor
53.98%
Investment Advisor/Hedge Fund
12.51%
Hedge Fund
3.17%
Individual Investor
2.47%
Endowment Fund
0.37%
Bank and Trust
0.32%
Private Equity
0.18%
Pension Fund
0.14%
Research Firm
0.10%
他の
26.77%
機関投資家保有株
更新時刻: Wed, Jan 21
更新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
129
59.51M
43.48%
--
2025Q4
149
60.27M
70.78%
+21.99M
2025Q3
46
45.42M
54.46%
+42.91M
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Capital International Investors
1.30M
1.52%
+1.30M
--
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
比率3.13%
Global X HealthTech ETF
比率1.75%
Fidelity Blue Chip Growth ETF
比率0.07%
T Rowe Price Small-Mid Cap ETF
比率0.06%
iShares Health Innovation Active ETF
比率0.02%
Schwab U.S. Small-Cap ETF
比率0.02%
Fidelity Nasdaq Composite Index ETF
比率0.01%
Schwab U.S. Broad Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
